COPENHAGEN, Denmark, July 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued over DKK 200 million to supply its MVA-BN® smallpox/mpox vaccine to a European country. This is another larger order in recent years from the country to strengthen national preparedness against biological threats and epidemics like smallpox and mpox.
Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country
Seeking Alpha / 1 hour from now 3 Views
Comments